Correction to: Mezaache et al. Harm Reduct J (2021) 18:11 https://doi.org/10.1186/s12954-021-00460-0
Following publication of the original article [1], the authors identified an error in Table 1.
Table 1.
N (%) or Median [IQR] |
Univariate analysis n = 209 | Multivariate analysis n = 197 | |||||
---|---|---|---|---|---|---|---|
OR | [95CI%] | p | AOR | [95CI%] | p | ||
Questionnaire | |||||||
Online | 162 (78) | 0 | |||||
Face-to-face | 47 (22) | 0.97 | [0.53; 1.77] | 0.924 | |||
Gender | |||||||
Male | 164 (79) | 0 | |||||
Female | 43 (21) | 0.75 | [0.41; 1.35] | 0.335 | |||
Age | |||||||
For 1 year | 34 [28–41] | 0.99 | [0.96; 1.02] | 0.619 | |||
Stable housing | |||||||
No | 81 (39) | 0 | |||||
Yes | 127 (61) | 0.72 | [0.43; 1.22] | 0.228 | |||
Employment | |||||||
No | 147 (70) | 0 | |||||
Yes | 62 (30) | 0.76 | [0.44; 1.30] | 0.319 | |||
Duration of opioid use | |||||||
For 1 year | 8 [4–11] | 1.01 | [0.96; 1.06] | 0.614 | |||
Duration of buprenorphine use | |||||||
For 1 year | 6 [4–10] | 1.02 | [0.97; 1.07.] | 0.528 | |||
Daily buprenorphine dose | |||||||
For 1 mg | 11 [8–16] | 1.04 | [1.00; 1.09] | 0.052 | 1.05 | [1.00; 1.10] | 0.043 |
Daily injection frequency | |||||||
For 1 injection | 3 [2–4] | 1.12 | [0.98; 1.27] | 0.086 | |||
Buprenorphine non-prescribed | |||||||
No | 187 (93) | 0 | |||||
Yes | 13 (7) | 3.98 | [1.09; 14.47] | 0.036 | 4.82 | [1.30; 17.85] | 0.019 |
Main reason for injecting buprenorphine | |||||||
To get “high” | 27 (15) | 0 | |||||
To avoid withdrawal symptoms or to feel good enough for daily functioning | 103 (59) | 0.96 | [0.44; 2.10] | 0.929 | |||
For the pleasure of the act | 41 (23) | 2.23 | [1.08; 4.61] | 0.030 | |||
Other non-opioid drugs used | |||||||
No | 49 (24) | 0 | |||||
Yes | 156 (76) | 1.03 | [0.56; 1.89] | 0.934 | |||
Alcohol consumption | |||||||
No | 124 (59) | 0 | |||||
Yes | 85 (41) | 0.99 | [0.60; 1.67] | 0.997 | |||
Lifetime number of injection-related complications (0–10) | |||||||
≤ 5 complications | 175 (84) | 0 | |||||
> 5 complications | 34 (16) | 2.29 | [1.08; 4.88] | 0.031 | 2.28 | [1.05; 4.93] | 0.037 |
Lifetime history of overdose | |||||||
No | 168 (80) | 0 | |||||
Yes | 41 (20) | 1.26 | [0.65; 2.47] | 0.493 | |||
Self-reported HCV status | |||||||
No | 129 (66) | 0 | |||||
Yes | 66 (34) | 0.87 | [0.50; 1.53] | 0.647 |
The correct table is given below.
The original article has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Mezaache et al. Harm Reduct J (2021) 18:11. https://doi.org/10.1186/s12954-021-00460-0